Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SOTAC PHARMACEUTICALS
Please provide your vote to see the results

SOTAC PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 9.8917.632.661.5112.26

What is the latest EV/Core EBITDA ratio of SOTAC PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of SOTAC PHARMACEUTICALS is 9.89 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20259.89
Mar202417.63
Mar20232.66
Mar20221.51
Mar202112.26

How is EV/Core EBITDA of SOTAC PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 9.89
-43.90
Mar2024 17.63
562.78
Mar2023 2.66
76.16
Mar2022 1.51
-87.68
Mar2021 12.26 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹123.2 Cr -11.2% -20.5% -11.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,999.0 Cr 3.6% 7% 15.3% Stock Analytics
DIVIS LABORATORIES ₹169,139.0 Cr 1.1% 5.8% 14.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,791.0 Cr 1.9% 12.3% 49.2% Stock Analytics
DR REDDYS LABORATORIES ₹109,664.0 Cr 1.8% 5.9% 14.8% Stock Analytics
CIPLA ₹107,685.0 Cr 1.6% 0.2% -5.4% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-11.2%

-20.5%

-11.2%

SENSEX

-2.5%

-6.1%

7%


You may also like the below Video Courses